肌生成抑制素、PCSK9或两者联合治疗缺血/再灌注损伤?

{"title":"肌生成抑制素、PCSK9或两者联合治疗缺血/再灌注损伤?","authors":"","doi":"10.33696/cardiology.3.029","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15510,"journal":{"name":"Journal of Clinical Cardiology","volume":"155 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Should we Target Myostatin, PCSK9 or Their Combination in Ischemia/Reperfusion Injury?\",\"authors\":\"\",\"doi\":\"10.33696/cardiology.3.029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15510,\"journal\":{\"name\":\"Journal of Clinical Cardiology\",\"volume\":\"155 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.33696/cardiology.3.029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.33696/cardiology.3.029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}